MedTrace Logo

Diagnostic Accuracy of Human Transcriptional Activator(MYB) Expression by ELISA Technique Versus Immmunohistochemistry in Detecting Salivary Gland Carcinomas

NCT03687294 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2020-07-21

No results posted yet for this study

Summary

in this resarch we will use ELISA Technique to estimate Human Transcriptional Activator(MYB) Expression .compare it by Immmunohistochemistry analysis of MYB Expression in the malignant and benign salivary gland tumor

Conditions

  • Malignant Neoplasm of Salivary Gland
  • Benign Neoplasm of Salivary Gland

Interventions

DEVICE

enzyme linked immunosorbent assay (ELISA)

ELISA measure MYB in tissue biopsy in benign and malignant salivary gland tumors

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-12
Primary Completion
2021-09-30
Completion
2021-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03687294 on ClinicalTrials.gov